Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy
Clinical trial NCT00456833 · COMPLETED
Trial details
- NCT number
- NCT00456833
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2011-03-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.